S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%
A daily business newspaper · Founded in 2026

Money Talk

Finance and markets: business, quotes, gold, energy and releases.

BYD and Geely Earnings Falter Under Domestic Price Pressure

A relentless price war in the Chinese domestic market is eroding margins for the nation's electric vehicle leaders, as BYD and Geely both reported third-quarter earnings that failed to meet analyst projections, despite aggressive efforts to offset cooling local demand with record-breaking surges in international sales volume.

BYD and Geely Earnings Falter Under Domestic Price Pressure

BYD saw its net profit climb 28% to 10.02 billion yuan, yet the figure fell significantly shy of the 11.1 billion yuan target anticipated by the market. Revenue reached 221.5 billion yuan, a 13.6% increase that still landed below forecasts. The cumulative results for the first nine months of the year paint a more sobering picture, with net income slipping 4.2% to 22.34 billion yuan.

Geely faced a similar reality, reporting a 28% profit increase to 4.84 billion yuan, missing expectations of 5.19 billion yuan. While the company moved 812,500 vehicles during the quarter, the industry-wide pivot toward exports is meeting resistance. Trade barriers are mounting as the European Union contemplates restrictions on Chinese hybrid imports, following previously imposed tariffs on battery-electric vehicles. Both automakers are now rushing to localize production, with BYD preparing a Hungarian plant for mass output and Geely securing manufacturing partnerships in Spain to navigate the shifting geopolitical landscape.

Share article
TelegramXFacebook

When reusing this material a link to Money Talk is required.

Comments (0)

Leave a comment

No comments yet. Be the first!